Integrated Development forPeptides, Oligonucleotides & Biologics

Process development, purification, analytics and scale-up-
from early feasibility to transfer-ready processes.

Peptides, Oligonucleotides & Biologics

Milligram-to-Kilogrom Development Experience

Integroted Synthesis, Purification & Analytics

Pilot-Scale & Technology-Tronsfer Readiness

OUR CAPABILITIES

End-to-End Capabilities Across Modalities

Peptides and Oligonucleotides

• SPPS. LPPS & Hybrid Synthesis
• Linear, Cyclic & Modised Peptides
• Oligonucleotide Synthesis
• Purification (HPLC, IEX, RP, UF/DF)
• Analytical Characterization

Biologics

• Cell Line /Strain Development
• Upstream Process Development
• Downstream Purification
• Characterication & Analytics
• Formulation & Stability
• Technology Transfer

Semi-Synthetic Molecules

• Custom Synthesis
• Conjugation & Derivatizetion
• Process Development
• Punfication & Isolation
• Scale.Up & Optimization

Analytical & Quality Support

. Method Development & Validation
· HPLC. UPLC. LC-MS/MS, CE. IC
. Impurity Profting
. Release Testing & Stabillty
. QA/QC & Regulatory Support

OUR DEVELOPMENT PATHWAY

From Concept to Commercial-Ready

01

02

03

04

05

06

Design / Cell Line Development

Feacibsity assessment and molecule or cell-Ine design

Development

Process development and optimization for your molecule.

Synthesis / Upstream Development

Chemical synthesis or upstream process development

Purification & Analytics

Purification process development with integrated analytics.

Release

Analytical testing. quality evalution and batch release.

Technology Transfer

Searniess transfer to manufecturing with full documentation

SELECTED CASE STUDIES

Proven Outcomes. Real Results.

Semi-Synthetic Purification

Challenge: Semi-synthetic purification

92.5%

Crude Purity

>99%

Final Purity

Columns Used: 10 mm & 50 mm

Lanreotide - Preparative Purification

Challenge: Semi-synthetic purification

88%

Crude Purity

98.5-99%

Final Purity

Reported Recovery: 40-45%

Semaglutide - Scale-Up Success

Focus: Side-chain chemistry, purification & scale-up

~50%

Crude Purity

98%

Target Purity

Scale: 0.5 kg synthesis batch

FACILITIES & SCALE

Built for Scale. Backed by Capability

100L

200L

450mm

40kg

10L & 100L

Available

QUALITY SYSTEMS

Quality by Design. Compliance in Practice.

Compliance Status

Manetri Pharma operates under robust quality systems aligned to international standards.

Current Status :

GMP Operations

Certification :

Information available
upon Request

LEADERSHIP

Experienced Leaders. Scientific Vision.

Mr.-L.-K.-Rao

Mr. L. K. Rao

Founder, Managing Director & Chairman

Mr.-Bhupesh-Nadella

Mr. Bhupesh Nadella

Senior General Manager (SGM)

Dr Praveer Gupta

Dr Praveer Gupta

Chief Scientific and Strategy Officer (CSSO)

Dr-D-Sreenath

Dr D Sreenath

Chief Operating Officer (COO)

Have a Complex Development Challenge?

Share your program details and our scientific team will help identify the right development pathway for you.